Register Today: Pre-Proposal Meeting/Webinar for NCI SBIR Technology Transfer Contract Topics

The NIH and NCI SBIR Development Center will host a pre-proposal public meeting and webinar for the following three Technology Transfer Contract Topics:

310 Simplified Tissue Microarray Instrument For Clinical and Research Settings
311 High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy
075 A Low Molecular Weight Thyroid-Stimulating Hormone Receptor Agonist for Thyroid Cancer *Note: This cancer-related topic is issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The funding will be provided by NIDDK while the receipt, review, and contracting will be handled by NCI.

Date: October 7, 2011
Time: 10:00 a.m. – 1:00 p.m.
Location: William H. Natcher Building, Room A, Bethesda, MD

Meeting participants will learn the technical background for these topics and the processes for licensing these technologies from NIH. The brief presentations will be followed by interactive questions and answers with the in-person and webinar audience. Interested applicants can participate in-person or via a live webinar.

For details on how to participate and to register, please click here.

 

To view the Technology Transfer Topics 310, 311, and 075, as well as the other contract funding opportunities available from the NCI, visit: http://sbir.cancer.gov/funding/contracts/.

The SBIR & STTR Programs are NCI’s engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. The SBIR & STTR Programs are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.

Sign up to receive updates about
SBIR & STTR funding opportunities at
sbir.cancer.gov

BioSpace Midwest Career Fair

BioMidwest Career Fair

Chicago Marriott Oak Brook

Tuesday, October 4, 2011

11am to 4pm

This event is a unique opportunity to meet face-to-face with local organizations who are actively hiring. It is not a typical open door Career Fair that invites anyone and everyone to attend. The BioMidwest Career Fair is strictly for higher level professionals within the biotech and pharmaceutical industry.

Minimum requirements for entry are a 4-year life science degree AND at least 2-years of industry experience. Postdocs and Ph.D. candidates are welcome to attend also.

Exhibiting Companies

• Emergent BioSolutions
• Gallus BioPharmaceuticals, LLC
• Integrated Project Management Co., Inc.
• Promega Corporation
• Therapeutic Proteins, Inc.

For more details and to register: http://www.biospace.com/jobs/career-fair-detail/?CareerFairId=221

IMDMC’s 2011 Annual Conference – 20 Years Serving the Device Community

Thursday October 6, 2011

Featuring:

Christy Foreman,
Director, Office of Device Evaluation, CDRH, FDA
&
Tim Ulatowski
Former Director of Compliance CDRH,
currently Principal, NDA Partners LLC

Location: Montage Meeting Facility
8580 Allison Pointe Blvd.
Indianapolis, IN 46250
Directions / Nearby Hotels

CLE Credits have been requested

 

Exclusively sponsored by:

Baker & Daniels, LLP

Agenda

9:15 am
Welcome
Danelle Miller, IMDMC President, Roche Diagnostics Corporation

9:30
Christy Foreman, Director, Office of Device Evaluation, CDRH, FDA

10:30
Break

10:45
Device clinical research: Evolution of government expectations & potential impact on your business
1. Recent enforcement trends
Leah Kendall, Attorney, Epstein Becker Green
2. FDA/OHRP efforts to modernize and revise regulations and guidance,
Gretchen Bowker, COO, Pearl Pathways
3. Case study: How increasing pressures in the clinical space may impact device development
Zimmer Clinical, TBD

11:15
Top Regulatory Issues
1. User Fees
Colleen Hittle, President & CEO, Anson Group
2. Post Market Surveillance
Sandra Williams, Consultant, Anson Group
3. EU Standards
Russ Gray, Principal Consultant/ Director of Device Operations & Combination Product, Anson Group
4. New Guidance / IOM Report / Update on FDA’s Innovation Initiatives/ UDI
Ralph Hall, Counsel, Baker & Daniels

12:15
Annual Business Meeting / Recognition of Past Presidents

12:30
Exhibit Break & Lunch

1:30
Tim Ulatowski, Principal, NDA Partners LLC
Former Compliance Director, CDRH

2:30
Break

2:45
Regulatory Affairs & Marketing:
Partnering for efficiency, compliance and clear communication?
Paul Leininger, Group Product Director, Hip Marketing, DePuy Orthopaedics, Inc

3:15
Top Compliance & Enforcement Issues
1. Anti-Corruption: Foreign Corrupt Practices Act and the UK Bribery Act
Carol Seaman, Vice President and Chief Compliance Officer, Cook Group Incorporated
2. Social Media and the Medical Device Sector Issues in Advertising and Promotion
Cynthia Kretz General Counsel, Cook Group Incorporated
3. Physician Payment Sunshine Provisions of the Patient Protection and Affordable Care Act
Dan Peterson, VP, Industry & Government Relations, Cook Group Inc.

4:00
Wrap Up & Adjourn

Register Online Now

Members: $125
Non-Members: $175

America Invents Act: Timing is Everything Seminar

Monday, September 19, 2011
Noon-1:30 p.m. (ET)

On September 8, 2011, the U.S. Senate passed the America Invents Act and the bill will be forwarded to President Obama who is expected to sign it immediately. Few American businesses will be unaffected by this Act, which changes the first-to-invent principles of patent law that have existed since the first patent law was enacted in 1790.

Please join us at 12:00 pm EDT for lunch and a discussion of how these changes will affect businesses. Our speakers will review the new laws and discuss relevant issues.

Speakers

• Brian P. Barrett, Senior Director and Assistant General Patent Counsel, Eli Lilly
• William A. Morrison, Vice President and Associate General Counsel, Intellectual Property for HIll-Rom
• Jim Burdett, Partner, Barnes & Thornburg LLP

Location:
The seminar will be broadcast to several different locations. See the bottom of this email for specific information

Date and Time:

Monday, Sept. 19, 2011
Registration/Lunch: Noon (ET)
Program: 12:30 – 1:30 p.m. (ET)

Registration:

RSVP by sending an email to inrsvp@btlaw.com.
When registering, please indicate which location you would like to attend.

There will be no charge for this event, but registration is required and seating is limited.

Seminar Locations

This seminar will be held live in Indianapolis but broadcast to several Barnes & Thornburg office locations.  When registering for this event please indicate the location you will attend.  For office locations, please visit us online at www.btlaw.com

Indianapolis I Grand Rapids I Atlanta I Fort Wayne I Minneapolis I Chicago I Columbus I
Los Angeles I South Bend I Elkhart

——————————————————————————–

About Barnes & Thornburg LLP
With more than 550 attorneys and other legal professionals, Barnes & Thornburg is one of the largest law firms in the country. The firm serves clients worldwide from its offices in Atlanta, Delaware, Chicago, Indiana, Los Angeles, Michigan, Minneapolis, Ohio and Washington, D.C. For more information, visit us online at http://www.btlaw.com.

Government Funding for Biodefense and Infectious Diseases R and D Activities

FreeMind Group is pleased to invite you to our 11th webinar in a series of summer educational webinars focusing on Biodefense & Infectious Diseases funding opportunities

Presenter:
Ayal Ronen, Senior Director, Marketing & Sales, FreeMind Group

Funding is available from various government sources to support R&D efforts for Biodefense, ranging from very early exploratory research all the way to end-stage clinical testing, and subsequent commercialization. These mechanisms differ in focus, potential and scope. Thus, choosing the right mechanism and proper presentation of the science is vital for award. In this webinar we will shed light on available funding opportunities, major challenges when approaching large scale grants and contracts and share with you our insight into maximizing chances for award.
In this webinar we will discuss:
• The NIAID – National Institute of Allergy and Infectious Diseases
• Biodefense and related programs
• Available opportunities for funding through NIAID, DoD and BARDA
• Major challenges in preparing large scale grants & contracts
The webinar is designed for experienced companies, as well as for first-time submitters, and researchers from the Academia who wish to increase their chances for as well as the total amount of funding awarded.

The webinar is FREE of charge.
Tuesday, September 13th at 1:00 PM-1:30 PM EDT
To register, please contact Hannah Rosencweig at (617) 648-0340, ext. 220, or at Hannah@freemindconsultants.com

Germany: Top Choice for U.S. Medical Technology – Webinar

Date: Tuesday, September 13, 2011
Time: noon EDT/ 11 a.m. CDT/ 9 a.m. PDT
Place: Online webinar on your computer
Fee: $75 per person

Join the U.S. Commercial Service’s webinar to gain expertise in using Germany as your gateway into the European Union as well as understanding the reimbursement challenges faced by American companies selling to the German Healthcare Market. The German Healthcare Market is the largest in Europe. It was 11.6 % of GDP (2009); employed 5.4 million people; and accounted for expenditures of € 278.3 billion in 2009. According to the German Medical Technology Association (BVMed), the medical devices segment employed 170,000 and generated expenditures of
€ 25 billion in 2009.

Webinar Overview
Presenters will discuss the benefits of starting with Germany versus the United Kingdom, even though Americans share heritage and language with Britain. In addition, current market issues, trends and opportunities as well as market entry strategies will be addressed. A comprehensive review of the German reimbursement practices and procedures is also included. Finally, an American exporter will share their experience in Germany and the European Union. Following the presentations, there will be an open question and answer period.

Scope
Discussion will include diagnostics, medical devices, medical equipment, instruments and disposables as well as dental equipment and supplies. Pharmaceuticals will not be included.

Presenters
Mr. Edmund Hain, Managing Director,BCNI, http://www.bcni-llc.com
Mr. Michael Ehlebracht, DMI-Systems AG, http://www.dmi-systems.de

Registration
For online registration, please click here

For direct e-mail inquiries, please contact Pompeya Lambrecht at Pompeya.Lambrecht@trade.gov or Julia Zorzi at Julia.Zorzi@trade.gov Via phone, Pompeya can be reached at 602.277.5223 and Julia at 412.644.2817.

Ernst and Young invites you to attend: The Looming Medical Device Excise Tax – How Will It Impact Indiana Companies

On March 30, 2010, President Obama signed into law the Health Care and Education Reconciliation Act of 2010, enacting a 2.3% excise tax on any medical device identified in Section 201(h) of the Federal Food, Drug & Cosmetic Act, including many that may not be at first glance thought of as a medical device. More that a year later most companies are still struggling or have yet to deal with uncertainties that still exist, including how and when the tax is determined and whether they will bear the burden of the tax. At this complimentary seminar, Ernst and Young’s Chris Ohmes and other national leaders on the topic will share insights and industry experience, as well as explain how Indiana companies may be able to plan for determining the correct tax to pay and how to minimize potential for overpayment. The mandatory tax takes effect January 1, 2013, but now is the time for Indiana companies to begin planning to comply with the tax and to reduce its impact on their bottom line.

Monday, October 3, 2011

Ernst & Young LLP
111 Monument Circle | 3rd Floor Tower Side, Conference Room C
Indianapolis, Indiana 46204

9:00 a.m. – 11:00 a.m.
Registration opens at 8:30 a.m. Continental breakfast will be provided.

Who should attend:
This course is appropriate for CFO, Controllers, Tax Directors, VPs of Finance.

RSVP
Please RSVP to Kathy Jacobson at kathy.jacobson@ey.com or call +1 317 681 7701 by Tuesday, September 27, 2011 to reserve your spot at this event. When RSVPing, please note if you’re also interested in a private meeting with members of Ernst & Young’s National Tax team on October 3rd from 11 a.m. – 12 p.m.

Space is limited and registration will close once capacity is reached.This course is complimentary. There is no registration fee. Continuing professional education (CPE) credits will be awarded.

For additional information, please contact Kathy Jacobson at kathy.jacobson@ey.com or call +1 317 681 7701.

IUPUI INNOVATION TO ENTERPRISE SUMMIT: TAKING UNIVERSITY INVENTIONS TO MARKET

Co-sponsored by:
IUPUI Office of the Vice Chancellor for Research
and
Indiana University Research and Technology Corporation

October 20, 2011

IUPUI Campus Center

Room 450 A & B

420 University Blvd.

Indianapolis, IN 46202

Has your work given you a great idea for a technology venture? Do you want to be a technology entrepreneur? Or to be part of a start-up team for a technology venture?

Join us on October 20 for a roundtable discussion led by an expert panel, who will provide practical insights for technology entrepreneurship, and explore opportunities and challenges specific to different business sectors.

A networking reception will follow the presentations, bringing together key players from IUPUI and the Indianapolis area business community–researchers, entrepreneurs, investors, and corporate executives.

For registration and more information:
http://crl.iupui.edu/Events/eventsRegistration.asp?id=2607

Agenda

1:30 – 2:00 – Registration

2:00 – 3:00 – Welcome

3:00 – 4:00 – Panel Discussion

4:00 – 4:15 break

4:15 – 5:15 – Keynote Presentation

5:15 -6:00 Networking Reception

To learn more, please contact:
Karen White
Office of the Vice Chancellor for Research
Phone: (317) 274-1083
Email: kfwhite@iupui.edu

Bringing Science to the Marketplace: The NCI’s Small Business Innovation Research Program

The Office of Cancer Centers Learning Series Webinar Presents:
Bringing Science to the Marketplace: The NCI’s Small Business Innovation Research Program

Do you have a small business that’s bringing advances in technology, treatments, and imaging to the forefront of cancer care?

Then join NCI’s Office of Cancer Centers for a FREE webinar Thursday, September 8, from 2:00 to 3:30 pm, ET, to learn how to tap into the resources of the National Cancer Institute’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs, two of the largest sources of early-stage technology financing in the United States.

During this webinar, NCI SBIR Development Center leaders will discuss new and existing initiatives to help small businesses further commercialize their innovations, including funding opportunities such as the recently announced $8M in contract funding opportunities, and the Phase II Bridge Award. Additionally, an SBIR grantee will share how he strategically leveraged the SBIR Program to help raise investor funding and advance his company’s cancer technology to the next stage of development.

Featured speakers and topics include:

Michael Weingarten, MA, Director, SBIR Development Center, NCI. He will present an overview of the NCI SBIR & STTR Programs

David Beylin, MS, MBA, DABSNM, Program Director, SBIR Development Center, NCI. He will provide guidance on current funding opportunities and tips for applicants

James Olson, MD, PhD, Member, Fred Hutchinson Cancer Research Center & President and Founder, Presage Biosciences, SBIR Program Grantee. He will discuss ways to harness the SBIR Program to maximize investments and advance technologies toward commercialization

Register Now

The webinar should run smoothly on PC and web-based platforms. If you are using a Mac, please use the web-based instructions. Instructions can be found at http://cancercenters.cancer.gov/Webinar/webinar_landing_page.html

If you have any technical or webinar questions, please do not hesitate to contact us at ncicenters-r@mail.nih.gov.

The SBIR & STTR Programs are NCI’s engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. The SBIR & STTR Programs are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.

SBIR/STTR Programs – The Gateway to Life Science Industry Non-Dilutive Funding

We are happy to accommodate requests for a re-broadcast of the following webinar:

SBIR/STTR Programs – The Gateway to Life Science Industry Non-Dilutive Funding

FreeMind Group is pleased to invite you to our 10th webinar in a series of summer educational webinars focusing on the SBIR/STTR opportunities

Presenter:
Ayal Ronen, Senior Director, Marketing & Sales, FreeMind Group

Oftentimes, the SBIR/STTR programs are a necessary step that BioTech and Medical Device companies take in order to display their strengths and graduate to become prime candidates for large scale awards in the millions of dollars. Despite the fierce competition and seemingly limiting factors, if properly approached and neatly executed, this program may prove to be a substantial source of funding complementary to traditional sources. To meet these challenges, and to turn out a top quality application, it is more important than ever to understand the intricate requirements of the SBIR/STTR program, thus maximizing your chances for award.

In this webinar we will discuss:
• SBIR/STTR regulations.
• Leveraging your SBIR/STTR money to large scale funding opportunities.
• Industry & academia collaboration
• Process for applying, requirements and limitations
• How to maximize chances for success
• Government funding as a strategic source of funding

The webinar is designed for experienced companies, as well as for first-time submitters, and researchers from the Academia who wish to increase their chances for award, as well as the total amount of funding awarded.
Tuesday, September 6th at 1:00 PM-1:30 PM EDT

The webinar is FREE of charge. To register, please contact Hannah Rosencweig at (617) 648-0340, ext. 221, or at Hannah@freemindconsultants.com